Literature DB >> 26404675

[Controversies in the surgical treatment for esophageal carcinoma and future investigation].

Yousheng Mao1, Jie He, Shugeng Gao, Qi Xue.   

Abstract

Esophageal carcinoma is one of the most prevalent malignancies in China. Surgical treatment remains to be important in the treatment for esophageal carcinoma. However, controversies exist in the surgical treatment for esophageal carcinoma including selection of appropriate surgical approach, extent of lymph node dissection, and optimization of minimally invasive esophagectomy processes and make it comparable to the open esophagectomy. All above disputed issues will be resolved through multi-center randomized controlled studies using clinical research network platform in the future. The clinical evidences produced by these studies will be used for revision of guidelines for esophageal carcinoma.

Entities:  

Mesh:

Year:  2015        PMID: 26404675

Source DB:  PubMed          Journal:  Zhonghua Wei Chang Wai Ke Za Zhi        ISSN: 1671-0274


  6 in total

Review 1.  Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma.

Authors:  Yousheng Mao; Zhentao Yu; Bin You; Wentao Fang; Brian Badgwell; Mark F Berry; DuyKhanh P Ceppa; Chun Chen; Haiquan Chen; Miguel A Cuesta; Xavier Benoit D'Journo; Guy D Eslick; Jianhua Fu; Xiangning Fu; Shugeng Gao; Jianxing He; Jie He; Yunchao Huang; Gening Jiang; Zhongmin Jiang; Jae Y Kim; Danqing Li; Hui Li; Shanqing Li; Deruo Liu; Lunxu Liu; Yongyu Liu; Xiaofei Li; Yin Li; Weimin Mao; Daniela Molena; Christopher R Morse; Nuria M Novoa; Lijie Tan; Qunyou Tan; Alper Toker; Ti Tong; Qun Wang; Benny Weksler; Lin Xu; Shidong Xu; Tiansheng Yan; Lanjun Zhang; Xingyi Zhang; Xun Zhang; Zhu Zhang; Xiuyi Zhi; Qinghua Zhou
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

2.  Immunomodulatory function of the active ingredients in traditional Chinese prescriptions on early stage esophageal cancer with dysplasia.

Authors:  Wenbo Jiang; Ning Qin; Tao Chen; Junwei Xu
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

3.  Mediastinoscopy-assisted transhiatal esophagectomy versus thoraco-laparoscopic esophagectomy for esophageal cancer: a single-center initial experience.

Authors:  Wenyi Liu; Xiaotong Guo; Hongbo Zhao; Xin Yu; Chunguang Wang; Longde Du; Feng Wang; Juwei Mu
Journal:  J Thorac Dis       Date:  2020-09       Impact factor: 2.895

Review 4.  Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review.

Authors:  Chunni Wang; Jingnan Wang; Zhaoli Chen; Yibo Gao; Jie He
Journal:  Chin J Cancer       Date:  2017-08-17

5.  Efficacy and safety of esophagectomy via left thoracic approach versus via right thoracic approach for middle and lower thoracic esophageal cancer: a multicenter randomized clinical trial (NST1501).

Authors:  You-Sheng Mao; Shu-Geng Gao; Yin Li; An-Lin Hao; Jun-Feng Liu; Xiao-Fei Li; Tie-Hua Rong; Jian-Hua Fu; Jian-Qun Ma; Mei-Qing Xu; Ren-Quan Zhang; Gao-Ming Xiao; Xiang-Ning Fu; Ke-Neng Chen; Wei-Min Mao; Yong-Yu Liu; Hong-Xu Liu; Zhi-Rong Zhang; Yan Fang; Dong-Hong Fu; Xu-Dong Wei; Li-Gong Yuan; Shan Muhammad; Wen-Qiang Wei; Philip Wai-Yan Chiu; Shane Lloyd; Francisco Schlottmann; Kenneth Meredith; Jose M Pimiento; Yi-Bo Gao; Jie He
Journal:  Ann Transl Med       Date:  2022-08

6.  Long-term survival of the middle and lower thoracic esophageal cancer patients after surgical treatment through left or right thoracic approach.

Authors:  Ding Yang; You-Sheng Mao; Jie He; Shu-Geng Gao; Ke-Lin Sun; Ju-Wei Mu; Qi Xue; Da-Li Wang; Yu-Shun Gao; Jun Zhao; Xiang-Yang Liu; De-Kang Fang; Jian Li; Yong-Gang Wang; Liang-Ze Zhang; Jin-Feng Huang; Bing Wang
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.